Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Retained Earnings (2020 - 2025)

Historic Retained Earnings for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $45.8 million.

  • Maravai Lifesciences Holdings' Retained Earnings fell 7254.19% to $45.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year decrease of 7254.19%. This contributed to the annual value of $140.9 million for FY2024, which is 5069.21% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Retained Earnings stood at $45.8 million, which was down 7254.19% from $71.4 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Retained Earnings ranged from a high of $404.8 million in Q4 2022 and a low of $24.1 million during Q1 2021
  • In the last 5 years, Maravai Lifesciences Holdings' Retained Earnings had a median value of $251.4 million in 2022 and averaged $226.8 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Retained Earnings skyrocketed by 2151135.83% in 2021 and then plummeted by 7295.83% in 2025.
  • Maravai Lifesciences Holdings' Retained Earnings (Quarter) stood at $184.6 million in 2021, then surged by 119.31% to $404.8 million in 2022, then fell by 29.41% to $285.7 million in 2023, then plummeted by 50.69% to $140.9 million in 2024, then plummeted by 67.49% to $45.8 million in 2025.
  • Its last three reported values are $45.8 million in Q3 2025, $71.4 million for Q2 2025, and $110.9 million during Q1 2025.